BioCentury
ARTICLE | Financial News

Pfizer allocates $600M to venture, with neuroscience a focus

June 6, 2018 12:01 PM UTC

Pfizer Inc. (NYSE:PFE) said it will invest $600 million in biotech and other emerging growth companies via Pfizer Ventures, with about $150 million devoted to early stage neuroscience companies.

Pfizer said initial areas of interest include neurodegeneration, neuroinflammation and neurometabolic diseases...

BCIQ Company Profiles

Pfizer Inc.